Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: A primer for radiologists

Journal of Computer Assisted Tomography

Volumn 32, Issue 1, 2008, Pages 1-3

  Prasad, Srinivasa R ^a   Jagirdar, Jaishree ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Gadolinium; MRI; Renal failure; Systemic fibrosis

Indexed keywords

GADOLINIUM;

CONDITION; GADOLINIA; MAGNETIC RESONANCE IMAGING CONTRAST AGENTS; NEPHROGENIC SYSTEMIC FIBROSIS; RENAL FAILURE; RENAL FUNCTIONS; SYMMETRICS; SYSTEMIC ADMINISTRATION; SYSTEMIC FIBROSE; YALE UNIVERSITY;

MAGNETIC RESONANCE IMAGING;

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADODIAMIDE; GADOLINIUM;

DOSE RESPONSE; DRUG MEGADOSE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; NEPHROGENIC FIBROSING DERMOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRIORITY JOURNAL; PUVA; RADIOLOGIST; REVIEW; SKIN DEFECT;

EID: 39849086632     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e31805d08ee     Document Type: Review

References (22)